Antigen concentration

The working conditions of the immunosensor (enzyme and antigen concentrations, dilutions of the antibodies, pH of the buffer solution) were found. The cholinesterase immobilized demonstrated the maximum catalytic activity in phosphate buffer solution with pH 8.0. The analytical chai acteristics of the sensor - the interval of the working concentrations and detection limit - have been obtained. The proposed approach of immunoassay made possible to detect 5T0 mg/ml of the bacterial antigen. 

Honda, S. A., Golstein, A. P Bhagavan, N. V. Prostate-specific antigen concentrations in serum in acute illnesses, Clin. Chem. 42,1785-1788 (1996). 

Figure 3 Layout of competitive solid-phase antibody immunoassay format in an incubation step antigen (Ag) and labeled antigen (Ag-L) compete for the solid-phase antibodybinding sites (Ab) after the solid-phase antibodies are washed, the activity of the bound labeled antigen is measured, and a calibration curve constructed. The measured signal is inversely proportional to the antigen concentration.

D. Following signal detection, select the optimal set of column wells (this will be dependent on the goal of the assay if, for instance, a screening assay is required with a certain cutoff concentration, e.g., 0.1 ng/mL for pesticides in water, then the labeled antigen concentration that yields a B/BO of 50% at 0.1 ng/mL will be ideal). 

Subsequent to a further washing step, to remove any unbound antibody-enzyme conjugate, the activity of the enzyme retained is quantified by a straightforward enzyme assay. The activity recorded is proportional to the quantity of antigen present in the sample assayed. A series of standard antigen concentrations may be assayed to allow construction of a standard curve. The standard curve facilitates calculation of antigen quantities present in unknown samples. 

The detection limits of the antibody-sandwich bioprobe was monitored by immersing the probe into vials containing variable antigen concentrations ranging from 10 to 100 ng/ml as shown in Figure 7.16. 

Noncompetitive ELISA methods are based on sandwich assays in which an excess supply of immobilized primary antibody, the capture antibody, quantitatively binds the antigen of interest and an enzyme-labeled secondary antibody is then allowed to react with the bound antigen forming a sandwich. A color reaction product produced by the enzyme is then used to measure the enzyme activity that is bound to the surface of the microtiter plate. Sandwich ELISA (noncompetitive) methods yield calibration curves in which enzyme activity increases with increasing free antigen concentration. 

If another antigen than PT is used, it can be a good idea to determine the optimal antigen concentration prior to the array experiment. 

The binding kinetics were characterized in terms of the apparent time constant (K pp = kf C + k ) where C = analyte concentration kf = association rate constant and k = dissociation rate constant. In closed loop experiments, a plateau value for K pp of 0.0024/s was reached at a linear flow rate of 2.67 mL/min. K ppWas foxmd to decrease with decreasing antigen concentration (C), with equilibrium achieved only at the highest level (1 pg/mL). The association rate constant Kf was calculated at 3.6 x 10 M/s for IgG binding. 

To determine the effect of spot size, various photolithographic masks were used to create arrays of square patterns at spot widths from 80 to 1145 p. The Kjjpp ( 1 standard deviation) did not vary over the spot size range of 80 to 1145 p under constant flow conditions at fixed levels of antigen concentration, and little effect of variation in spot size was noted on mean binding. 

As shown in Fig. 21, in a direct ELISA the unlabeled antigen (a range of standard antigen concentrations or unknown samples) is attached to the solid phase. Enzyme-conjugated (labeled) primary antibody is then added. After incubation and washing of the plate... 

Finasteride reduces serum prostate-specific antigen concentrations (60). In participants in the Prostate Cancer Prevention Trial who had an end of study biopsy (928... 

---